Theravance Biopharma (TBPH) Share-based Compensation (IS) (2014 - 2023)
Theravance Biopharma's Share-based Compensation (IS) came in at $6.26 million for Q2 2023, down 35.5% from $9.71 million a year earlier and down 10.8% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Share-based Compensation (IS) (2014 - 2023) Analysis & Trends
Over the trailing twelve months to Jun 30, 2023, Theravance Biopharma reported Share-based Compensation (IS) of $28.77 million, down 48.2% year-over-year; for FY2022, it was $39.73 million, down 36.0% from FY2021.
- Share-based Compensation (IS) carries a five-year compound annual growth rate of -4.2% (FY2017 to FY2022).
- Going back by year, Share-based Compensation (IS) was $62.06 million in FY2021 (-1.5%), $62.98 million in FY2020 (+4.2%), $60.45 million in FY2019 (+17.8%) and $51.31 million in FY2018 (+4.4%).
- The Q2 2023 figure represents the lowest quarterly Share-based Compensation (IS) in data going back to Q3 2014.
- Year-over-year, Share-based Compensation (IS) has declined for six consecutive quarters, with an average decline of 28.6% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation (IS) over five years came in Q4 2019 (growth of 104.1%), and the weakest in Q4 2022 (a decline of 58.9%).
- Business Quant data shows TBPH's Share-based Compensation (IS) at $7.02 million (Q1 2023), $6.95 million (Q4 2022) and $8.53 million (Q3 2022) in the three quarters before Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 6.26 Mn |
| Mar 31, 2023 | 7.02 Mn |
| Dec 31, 2022 | 6.95 Mn |
| Sep 30, 2022 | 8.53 Mn |
| Jun 30, 2022 | 9.71 Mn |
| Mar 31, 2022 | 14.55 Mn |
| Dec 31, 2021 | 16.92 Mn |
| Sep 30, 2021 | 14.37 Mn |
| Jun 30, 2021 | 14.94 Mn |
| Mar 31, 2021 | 15.83 Mn |
| Dec 31, 2020 | 15.55 Mn |
| Sep 30, 2020 | 15.56 Mn |
| Jun 30, 2020 | 16.59 Mn |
| Mar 31, 2020 | 15.28 Mn |
| Dec 31, 2019 | 23.91 Mn |
| Sep 30, 2019 | 13.02 Mn |
| Jun 30, 2019 | 11.30 Mn |
| Mar 31, 2019 | 12.22 Mn |
| Dec 31, 2018 | 11.71 Mn |
| Sep 30, 2018 | 11.75 Mn |
API Access
Theravance Biopharma Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();